Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
3,904.20
3,875.66
3,681.74
3,664.54
2,909.96
2,465.55
1,696.32
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,904.20
3,875.66
3,681.74
3,664.54
2,909.96
2,465.55
1,696.32
Raw Material Cost
2,309.28
2,101.87
1,849.73
1,651.41
1,257.34
1,229.04
875.76
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
306.13
310.83
237.92
205.19
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
78.04
82.67
59.67
94.14
60.72
23.26
9.58
Selling and Distribution Expenses
463.51
540.96
579.66
592.30
545.95
416.04
278.83
Other Expenses
-9.59
-7.22
-7.81
-11.67
8.23
12.44
8.01
Total Expenditure (Excl Depreciation)
3,061.01
2,964.17
2,648.85
2,426.35
1,946.28
1,792.74
1,244.24
Operating Profit (PBDIT) excl Other Income
843.1999999999999
911.5
1032.9
1238.1999999999998
963.7
672.8
452.1
Other Income
112.91
122.82
205.70
53.95
48.33
27.72
25.21
Operating Profit (PBDIT)
1,260.34
-54.83
1,368.15
1,378.34
1,057.33
745.87
516.75
Interest
78.04
82.67
59.67
94.14
60.72
23.26
9.58
Exceptional Items
-18.82
-3.01
-5.06
9.09
0.40
0.00
0.00
Gross Profit (PBDT)
1,594.92
1,773.79
1,832.02
2,013.13
1,652.62
1,236.51
820.57
Depreciation
175.04
154.25
139.72
93.42
84.77
45.19
40.18
Profit Before Tax
988.44
-294.76
1,163.70
1,199.87
912.23
677.42
466.99
Tax
165.93
-105.31
98.85
139.84
117.98
74.12
43.17
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
826.14
-189.45
1,090.83
1,059.29
806.12
604.96
424.55
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
826.14
-189.45
1,090.83
1,059.29
806.12
604.96
424.55
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.05
-0.00
-4.31
4.62
-9.47
1.28
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
826.10
-189.45
1,086.52
1,063.92
796.65
606.24
424.55
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
6,491.67
5,801.97
6,170.64
5,377.92
3,722.44
2,966.49
2,421.11
Earnings per share (EPS)
0.5
-0.12
0.68
0.67
0.51
0.38
0.27
Diluted Earnings per share
0.5
-0.12
0.68
0.67
0.51
0.38
0.27
Operating Profit Margin (Excl OI)
24.91%
-8.56%
27.78%
33.59%
31.76%
27.29%
26.61%
Gross Profit Margin
29.8%
-3.63%
35.4%
35.29%
34.26%
29.31%
29.9%
PAT Margin
21.16%
-4.89%
29.63%
28.91%
27.7%
24.54%
25.03%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 0.74% vs 5.27% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 536.17% vs -117.43% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 745.69% vs -115.29% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -5.68% vs 38.53% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
3,904.20
0
3,904.20
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,904.20
0
3,904.20
Raw Material Cost
2,309.28
0
2,309.28
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
306.13
0
306.13
Power Cost
0
0
0.00
Manufacturing Expenses
78.04
0
78.04
Selling and Distribution Expenses
463.51
0
463.51
Other Expenses
-9.59
0.00
-9.59
Total Expenditure (Excl Depreciation)
3,061.01
0
3,061.01
Operating Profit (PBDIT) excl Other Income
843.19
0.00
843.19
Other Income
112.91
0
112.91
Operating Profit (PBDIT)
1,260.34
0
1,260.34
Interest
78.04
0
78.04
Exceptional Items
-18.82
0
-18.82
Gross Profit (PBDT)
1,594.92
0
1,594.92
Depreciation
175.04
0
175.04
Profit Before Tax
988.44
0
988.44
Tax
165.93
0
165.93
Provisions and contingencies
0
0
0.00
Profit After Tax
826.14
0
826.14
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
826.14
0
826.14
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.05
0
-0.05
Other related items
0.00
0.00
0.00
Consolidated Net Profit
826.10
0
826.10
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
6,491.67
0
6,491.67
Earnings per share (EPS)
0.50
0
0.50
Diluted Earnings per share
0.50
0
0.50
Operating Profit Margin (Excl OI)
24.91%
0%
0.00
24.91%
Gross Profit Margin
29.80%
0%
0.00
29.80%
PAT Margin
21.16%
0%
0.00
21.16%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 390.42 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 0.74% vs 5.27% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 82.61 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 536.17% vs -117.43% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 114.74 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 745.69% vs -115.29% in Dec 2023
Annual - Interest
Interest 7.80 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -5.68% vs 38.53% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 24.91%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






